Literature DB >> 3867331

Stability of imipenem in Mueller-Hinton agar stored at 4 degrees C.

P L Turgeon, C Desrochers.   

Abstract

The purpose of the present study was to measure the stability of imipenem in Mueller-Hinton agar stored at 4 degrees C over time. MICs for Staphylococcus aureus ATCC 25923, Streptococcus faecalis ATCC 29212, Escherichia coli ATCC 25922, and Pseudomonas aeruginosa ATCC 27853 were determined in triplicate daily for up to 15 days. The calculated mean time to observe a shift of one dilution in MIC endpoints was 4.33 +/- 1.25 days. For routine work, imipenem agar dilution plates should be prepared within 48 to 72 h of the test.

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 3867331      PMCID： PMC176367          DOI： 10.1128/AAC.28.5.711

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  5 in total

1.  Bioactivity of imipenem as a function of medium, time, and temperature.

Authors:  E J Baron; J A Hindler
Journal:  Antimicrob Agents Chemother       Date:  1984-06       Impact factor: 5.191

2.  Effects of storage temperature and pH on the stability of eleven beta-lactam antibiotics in MIC trays.

Authors:  D J Nickolai; C J Lammel; B A Byford; J H Morris; E B Kaplan; W K Hadley; G F Brooks
Journal:  J Clin Microbiol       Date:  1985-03       Impact factor: 5.948

3.  MK0787 (N-formimidoyl thienamycin): evaluation of in vitro and in vivo activities.

Authors:  H Kropp; J G Sundelof; J S Kahan; F M Kahan; J Birnbaum
Journal:  Antimicrob Agents Chemother       Date:  1980-06       Impact factor: 5.191

4.  Antibacterial activities of a new stabilized thienamycin, N-formimidoyl thienamycin, in comparison with other antibiotics.

Authors:  T Kesado; T Hashizume; Y Asahi
Journal:  Antimicrob Agents Chemother       Date:  1980-06       Impact factor: 5.191

5.  Comparative in-vitro activity of MK0787 (N-formimidoyl thienamycin) against 540 blood culture isolates.

Authors:  D L Cohn; L G Reimer; L B Reller
Journal:  J Antimicrob Chemother       Date:  1982-03       Impact factor: 5.790
  5 in total
  6 in total

1.  Discrepancies in susceptibility test results for imipenem employing different in vitro test methods and DIN 58,940 breakpoints.

Authors:  H Grimm; C Hauss; A C Rodloff
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-01       Impact factor: 3.267

2.  Comparative evaluation of a prototype chromogenic medium (ChromID CARBA) for detecting carbapenemase-producing Enterobacteriaceae in surveillance rectal swabs.

Authors:  Georgia Vrioni; Ioannis Daniil; Evangelia Voulgari; Kyriaki Ranellou; Vasiliki Koumaki; Sandrine Ghirardi; Maria Kimouli; Gilles Zambardi; Athanassios Tsakris
Journal:  J Clin Microbiol       Date:  2012-03-29       Impact factor: 5.948

3.  Pharmacodynamic effects of extended dosing intervals of imipenem alone and in combination with amikacin against Pseudomonas aeruginosa in an in vitro model.

Authors:  B J McGrath; K C Lamp; M J Rybak
Journal:  Antimicrob Agents Chemother       Date:  1993-09       Impact factor: 5.191

4.  Antimicrobial susceptibility testing of carbapenems: multicenter validity testing and accuracy levels of five antimicrobial test methods for detecting resistance in Enterobacteriaceae and Pseudomonas aeruginosa isolates.

Authors:  Christine D Steward; Jasmine M Mohammed; Jana M Swenson; Sheila A Stocker; Portia P Williams; Robert P Gaynes; John E McGowan; Fred C Tenover
Journal:  J Clin Microbiol       Date:  2003-01       Impact factor: 5.948

5.  Heteroresistance to meropenem in carbapenem-susceptible Acinetobacter baumannii.

Authors:  Alexandros Ikonomidis; Evangelia Neou; Vassiliki Gogou; Georgia Vrioni; Athanassios Tsakris; Spyros Pournaras
Journal:  J Clin Microbiol       Date:  2009-10-14       Impact factor: 5.948

6.  Pseudoresistance of Pseudomonas aeruginosa resulting from degradation of imipenem in an automated susceptibility testing system with predried panels.

Authors:  R L White; M B Kays; L V Friedrich; E W Brown; J R Koonce
Journal:  J Clin Microbiol       Date:  1991-02       Impact factor: 5.948
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.